BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30056112)

  • 1. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
    Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
    Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
    Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
    Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
    Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
    Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
    Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
    Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
    He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
    J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
    Longerich T
    Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway.
    Xu Z; Hu J; Cao H; Pilo MG; Cigliano A; Shao Z; Xu M; Ribback S; Dombrowski F; Calvisi DF; Chen X
    Exp Mol Med; 2018 Jan; 50(1):e417. PubMed ID: 29303510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
    Li Y; Ye Y; Feng B; Qi Y
    J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
    Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
    Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.
    Yin YT; Shi L; Wu C; Zhang MY; Li JX; Zhou YF; Wang SC; Wang HY; Mai SJ
    Med Oncol; 2024 Feb; 41(3):79. PubMed ID: 38393440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.
    Sun J; Li T; Zhao Y; Huang L; Sun H; Wu H; Jiang X
    Mol Cell Biochem; 2018 Apr; 441(1-2):1-7. PubMed ID: 28852924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
    Liu F; Zhang W; Yang F; Feng T; Zhou M; Yu Y; Yu X; Zhao W; Yi F; Tang W; Lu Y
    Sci Rep; 2016 Feb; 6():21260. PubMed ID: 26879559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt/mTOR pathway.
    Bi J; Liu Q; Sun Y; Hu X; He X; Xu C
    J Recept Signal Transduct Res; 2021 Dec; 41(6):593-603. PubMed ID: 33108937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal role of mTOR signaling in hepatocellular carcinoma.
    Villanueva A; Chiang DY; Newell P; Peix J; Thung S; Alsinet C; Tovar V; Roayaie S; Minguez B; Sole M; Battiston C; Van Laarhoven S; Fiel MI; Di Feo A; Hoshida Y; Yea S; Toffanin S; Ramos A; Martignetti JA; Mazzaferro V; Bruix J; Waxman S; Schwartz M; Meyerson M; Friedman SL; Llovet JM
    Gastroenterology; 2008 Dec; 135(6):1972-83, 1983.e1-11. PubMed ID: 18929564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.